Expression of Cyclooxygenase-1 and -2 in Human Colorectal Cancer

Cancer Research

Volumn 55, Issue 17, 1995, Pages 3785-3789

  Sano, Hajime ^a   Kawahito, Yutaka ^a   Hashiramoto, Akira ^a   Mukai, Shigehiko ^a   Asai, Kiyoshi ^a   Kimura, Shigeru ^a   Kato, Haruki ^a   Kondo, Motoharu ^a   Wilder, Ronald L ^b   Hla, Timothy ^c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE; SULINDAC;

ARTICLE; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; ENZYME ACTIVITY; ENZYME LOCALIZATION; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADENOCARCINOMA; ADULT; AGED; AMINO ACID SEQUENCE; COLONIC NEOPLASMS; FEMALE; HUMAN; ISOENZYMES; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; RECTAL NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029117472     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Kune, G. A., Kune, S., and Watson, L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48: 4399–4404, 1988.
2. Thun, M. J., Namboodiri, M. M., and Heath, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N. Eng. J. Med., 325: 1593–1596, 1991.
3. Rosenberg, L., Palmer, J. R., Zauner, A. G., Warshauer, M. E., Stolley, P. D., and Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of the large-bowel cancer. J. Natl. Cancer Inst., 83: 355–358, 1991.
4. Suh, O., Mettlin, C., and Petrelli, N. J. Aspirin use, cancer, and polyps of the large bowel. Cancer (Phila.), 72: 1171–1177, 1993.
5. Greenberg, E. R., Baron, J. A., Freeman, D. H. Jr., Mandel, J. S., and Haile, R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Group. J. Natl. Cancer Inst., 85: 912–916, 1993.
6. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., and Willett, W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121: 241–246, 1994.
7. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenoma with sulindac in familial adenomatous polyposis. N. Eng. J. Med., 328: 1313–1316, 1993.
8. Spagnesi, M. T., Tonelli, F., Dolara, P., Caderni, G., Valanzano, R., Anastasi, A., and Bianchini, F. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterology, 106: 362–366, 1994.
9. Narisawa, T., Sato, M., Tani, M., Kudo, T., Takahashi, T., and Goto, A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res., 41: 1954–1957, 1981.
10. Pollard, M., and Luckert, P. H. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science (Washington DC), 214: 558–559, 1981.
11. Rao, C. V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G., and Reddy, B. S. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, a-difluoromethylornithine, 16 a-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res., 57: 4528–4534, 1991.
12. Moorghen, M., Ince, P., Finney, K. J., Sunter, J. P., Appleton, D. R., and Watson, A. J. A protective effect of sulindac against chemically-induced primary colonic tumours in mice. J. Pathol., 156: 341–347, 1988.
13. Reddy, B. S., Maruyama, H., and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, and nonsteroidal antiinflammatory drugs during different stages of rat colon tumor development. Cancer Res., 47: 5340–5346, 1987.
14. Marnett, L. J. Polycystic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci., 29: 531–546, 1981.
15. Smith, B. J., Curtis, J. F., and Eling, T. E. Bioactivation of xenobiotics by prostaglandin H synthetase. Chem. Biol. Interact., 79: 245–264, 1991.
16. Dubois, R. N., Tsujii, M., Bishop, P., Awad, J. A., Makita, K., and Lanahan, A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol., 266: G822-G827, 1994.
17. Dubois, R. N., Awad, J., Morrow, J., Roberts, L. J., and Bishop, P. R. Regulation of eicosanoid production and mitogenesis in rat epithelial cells by transforming growth factor-cr and phorbol esters. J. Clin. Invest., 93: 493–498, 1994.
18. Hla, T., Ristimaki, A., Appleby, S., and Barriocanal, J. G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann. NY Acad. Sci., 696: 197–204, 1993.
19. Craven, P. A., Saito, R., and DeRubertis, F. R. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. J. Clin. Invest., 72: 1365–1375, 1983.
20. DeRubertis, F. R., Craven, P. A., and Saito, R. 16,16-dimethyl prostaglandin Ej suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin. Gastroenterology, 89: 1054–1063, 1985.
21. Bennett, A., Civier, A., Hensby, C. N., Melhuish, P. B., and Stamford, I. F. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut, 28: 315–318, 1987.
22. Maxwell, W. J., Kelleher, D., Keating, J. J., Hogan, F. P., Bloomfield, F. J., MacDonald, G. S., and Keeling, P. W. N. Enhanced secretion of prostaglandin Ej by tissue-fixed macrophages in colonic carcinoma. Digestion, 47: 160–166, 1990.
23. Smith, W. L., and Marnett, L. J. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim. Biophys. Acta, 1083: 1–17, 1991.
24. Kujubu, D. A., Reddy, S. T., Fletcher, B. S., and Herschman, H. R. Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J. Biol. Chem., 268: 5425–5430, 1993.
25. Simmons, D. L., Xie, W., Chipman, J. G., and Evett, G. E. Multiple cyclooxygenase: cloning of a mitogen-inducible form. In: J. M. Bailey (ed), Prostaglandin, Leuko-trienes, Lipoxins and PAF, pp. 57–78. New York: Plenum Press, 1991.
26. Dewitt, D. L., Day, J. S., Sonnenburg, W. K., and Smith, W. L. Concentration of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta. J. Clin. Invest., 72: 1882–1888, 1983.
27. Smith, W. L., and Bell, T. G. Immunohistochemical localization of prostaglandin forming cyclooxygenase in renal cortex. Am. J. Physiol., 235: F451-F457, 1978.
28. Dewitt, D. L., and Smith, W. L. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. USA, 85: 1412–1416, 1988.
29. Funk, C. D., Funk, L. B., Kennedy, M. E., Pong, A. S., and Fitzgerald, G. A. Human platelet/erythroleukemia cell prostaglandin G/H synthetase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J., 5: 2304–2312, 1991.
30. Hla, T., and Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA, 89: 7384–7388, 1992.
31. Kujubu, D. A., Fletcher, B. S., Varnium, B. C., Lim, R. W., and Herschman, H. R. TS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266: 12866–12872, 1991.
32. O'Banion, M. K., Winn, V. D., and Young, D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA, 89: 4888–4892, 1992.
33. Sano, H., Hla, T., Maier, J. A. M., Crofford, L. J., Case, J. P., Maciag, T., and Wilder, R. L. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J. Clin. Invest., 89: 97–108, 1992.
34. Crofford, L. J., Wilder, R. L., Ristimaki, A. P., Sano, H., Remmers, E. F., Epps, H. R., and Hla, T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-10, phorbol ester, and corticosteroids. J. Clin. Invest., 93: 1095–1101, 1994.
35. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrebach, S., and Dubois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183–1188, 1994.
36. Sano, H., Engleka, K., Mathern, P., Ma, T., Crofford, L. J., Remmers, E. F., Jelsema, C. L., Goldmuntz, E., Maciag, T., and Wilder, R. L. Coexpression of platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis. J. Clin. Invest., 91: 553–565, 1993.
37. Kawahito, Y., Sano, H., Kawata, M., Yuri, K., Mukai, S., Yamamura, Y., Kato, H., Chrousos, G. P., Wilder, R. L., and Kondo, M. Local secretion of corticotropin-releasing hormone by enterochromaffin cells in human colon. Gastroenterology, 106: 859–865, 1994.
38. Sano, H., Forough, R., Maier, J. A. M., Case, J. P., Jackson, A., Engleka, K., Maciag, T., and Wilder, R. L. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J. Cell Biol., 110: 1417–1426, 1990.
39. Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., and Hwang, D. Selective expression of mitogen-inducible cyclooxygenase in macrophage stimulated with lipopolysaccharide. J. Biol. Chem., 26: 25934–25938, 1992.
40. Hempel, S. L., Monick, M. M., and Hunninghake, G. W. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J. Clin. Invest., 93: 391–396, 1994.
41. Mikkelson, H. B., Rumessen, J. J., and Qvortrup, K. Prostaglandin H synthase immunoreactivity in human gut: an immunohistochemical study. Histochemistry, 96: 295–299, 1991.
42. Parhar, R. S., and Lara, P. K. PGE2-mediated inactivation of various killer lineage cells by tumor bearing host macrophage. J. Leukocyte Biol., 46: 474–484, 1988.
43. Chouaib, S., Welte, K., Mertelsmann, R., and Dupont, B. Prostaglandin Ej acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression. J. Immunol., 135: 1172–1179, 1985.
44. Lara, P. K., and Parhar, R. S. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ. Cancer Res., 48: 1072–1079, 1988.
45. Elkashab, M., Paehar, R. S., and Lala, P. K. Chronic indomethacin therapy reverses PGE2-mediated suppression of interferon-gamma and IL-2 receptor development on lymphocytes of tumor bearing mice and augments receptor developing during therapy with IL-2, interferon-gamma or interferon-gamma plus IL-2 (Abstract). Proceedings of the XlXth International Leukocyte Culture Conference, Banff, Alverta, p. 79, 1988.
46. Nolan, R. D., Danilowicz, R. M., and Eling, T. E. Role of arachidonic acid metabolism in mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor. Mol. Pharmacol., 33: 650–656, 1988.
47. Ziche, M., Jones, J., and Gullino, P. M. Role of prostaglandin E, and copper in angiogenesis. J. Natl. Cancer Inst., 6: 475–482, 1982.
48. Furstenberger, G., Berry, D. L., Sorg, B., and Marks, F. Skin tumor promotion by phorbol esters is a two-stage process. Proc. Natl. Acad. Sci. USA, 78: 7722–7726, 1981.
49. Furstenberger, G., Gross, M., and Marks, F. Eicosanoid and multistage carcinogenesis in NMRI mouse skin: role of prostaglandin E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis, 10: 91–96, 1989.
50. Hubbard, W. C., Alley, M. C., McLemore, T. L., and Boyd, M. R. Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors. Cancer Res., 48: 4770–4775, 1988.
51. Otto, J. C., DeWitt, D. L., and Smith, W. L. JV-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem., 268: 18234–18242, 1993.
52. Otto, J. C., and Smith, W. L. The orientation of prostaglandin endoperoxide syn-thases-1 and -2 in the endoplasmic reticulum. J. Biol. Chem., 269: 19868–19875, 1994.
53. Flammang, T. J., Yamazoe, Y., Benson, R. W., Roberts, D. W., Potter, D. W., Chu, D. Z. J., Lang, N. P., and Kadlubar, F. F. Arachidonic acid-dependent peroxidattve activation of carcinogenic arylamines by extrahepatic human tissues microsomes. Cancer Res., 49: 1977–1982, 1989.